期刊文献+

胶体金检测抗环瓜氨酸肽抗体性能评价 被引量:3

Performance Evaluation of Colloidal Gold Test for the Detection of Anti-cyclic Citrullinated Peptide Antibody
下载PDF
导出
摘要 目的对胶体金免疫层析(GICA)技术检测患者血清抗环瓜氨酸肽(CCP)抗体进行性能验证和评价。方法采用酶联免疫吸附试验(ELISA)和GICA,同时对104例可疑类风湿性关节炎(RA)患者进行抗-CCP抗体检测,计算两种方法检测结果的阴性符合率、阳性符合率、总符合率以及Kappa值。用±20%临界值浓度标本各重复检测20次,记录阴性和阳性结果数,验证GICA法重复性。结果两种方法检测结果比较,阴性符合率、阳性符合率、总符合率、Kappa值分别为92%、100%、96%、0.92。GICA法检测+20%临界值浓度标本结果阳性数为20次,阳性率100%;-20%临界值浓度标本结果阴性数为15次,阴性率为75%。结论 GICA法与ELISA法检测抗-CCP抗体结果一致性良好,而且GICA方法简单、快速,敏感性和特异性较高,是早期筛查类风湿性关节炎值得推广的方法。 Objective To verify and evaluate the performance of the anti-cyclic citrullinated peptide antibody ( CCP ) by the rapid colloidal gold immunoehromatographie strip. Methods All 104 serum samples were detected parallelly by ELISA and GICA, calculating the negative rate, the positive rate, the total rate and Kappa value. The samples of + 20% concentration of cutoff were detected 20 times repeatedly, recording the positive and negative number. Results The negative rate, the positive rate, the total rate and Kappa value of the two test were 92%, 100%,96% and 0.92. The positive rate of +20% concentration of cutoff was 100% , and the negative rate of -20% concentration of cutoff was 75%. Conclusion The consistency of the ELISA and GICA for the anti-cyclic citrullinated peptide antibody is good. GICA kit is simple and easy to operate, relatively high sensitivity and specificity. It is a useful assay in the clinical early screening inspecting of RA.
出处 《中国现代医生》 2011年第32期84-85,90,共3页 China Modern Doctor
关键词 抗环瓜氨酸肽抗体 胶体金免疫层析法 性能评价 Anti-cyclic citrullinated peptide antibody Colloidal gold immunochromatography Performance evaluation
  • 相关文献

参考文献6

  • 1Bukhari M, Harrosiont B, Lunt M, et al . Time to first occurrence of eroaions in inflammatory polyarthritis: results from prospective community-based study[J]. Arthritis Rheum ,2001,44 ( 6 ) : 1248-1253.
  • 2Wang WS, Chen PM, Su Y. Colorectal carcinoma: from tumorigenesis to treatment [J]. Cell Mol Life Sci, 2006,63 ( 6 ) : 663-671.
  • 3Goldbach-Mansky R, Lee J, McCoy A, et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset[J]. Arthritis Res, 2000,2 ( 3 ) : 236-243.
  • 4Bizzaro N, Mazzanti G, Tonuti E, et al. Diagnostic accuracy of the anti- citrulline antibody as say for rhumatoida rthritis[J]. Clin Chem, 2001,47 ( 6 ) : 1089-1093.
  • 5Suzuki K, Sawada T, Murakami A, et al. High diagnostic performance of ELISA detection of antibodies to citnrllinated antigens in rheumatoid arthritis[J]. Scand J Rheumatol,2003,32 ( 4 ) : 197-204.
  • 6汤卫菊.抗环状瓜氨酸肽(CCP)抗体检测的临床应用[J].中国医药导报,2007,4(04Z):103-103. 被引量:2

二级参考文献2

共引文献1

同被引文献42

  • 1唐福林.应规范类风湿关节炎的诊断与治疗[J].中华医学杂志,2004,84(12):971-973. 被引量:6
  • 2张清,刘或,徐沪济.类风湿关节炎抗环瓜氨酸肽(CCP)抗体的快速筛查[D].北京:全国第八届中西医结合风湿病学术会议,2010.
  • 3Schellekens G A, De Jong B A W, Van Den Hoogen F H, et al.Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis specific autoantibodies[J].J Clin Invest, 1998,101(1): 273-281.
  • 4Schellekens G A, Visser H, De properties of rheumatoid arthriti JongBAW, et s antibodies rec eitrullnated peptide[J].Arthritis Rheum, 2000, 43(1) al.The diagnostic ognizing a cyclic 155-163.
  • 5Vander Cruyssen B, Hoffman IEA, Zmierczak H, et al. Anti- citrullinated peptide antibodies may occur in patients with psoriatic arthritis [ J ]. Ann Rheum Dis, 2005,64 ( 8 ) : 1145- 1149.
  • 6Bomhardieri M, Alessandri C, Labbadia G, et al. Role of anti cyclic citrullinated peptide antibodies in discriminating pa- tients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement[J]. Arthritis Res Ther,2004,6(2): R137-R141.
  • 7Ezzat WM,Raslan HM,Aly AA,et al. Anti cyclic citrullinated peptide antibodies as a discriminating marker between rheu matoid arthritis and chronic hepatitis C-related polyarthropa thy[J]. Rheumatol lnt, 2011, 31 ( 1 ) : 65-69.
  • 8Forslind K, Ahlmen M, Eberhardt K, et al. Prediction of radio logical outcome in early rheumatoid arthritis in clinical prac tice: role of antibodies to citrullinated peptides (anti CCP) [J]. Ann l;/heum Dis,2004,63(9) :1090-1095.
  • 9Alessandri C, Bombardieri M, Papa N, et al. Decrease of anti- cyclic citrllinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is. associated with clinical improvement [J]. Ann Rheum Dis,2004,63(10) : 1218-1221.
  • 10Sehellekens GA,De Jong BA,Van den Hoogen FH,et al. Cit- rulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies[J]. J Clin Invest,1998,101(1) :273-281.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部